Skip to main content
. 2003 Jul;47(7):2208–2216. doi: 10.1128/AAC.47.7.2208-2216.2003

TABLE 4.

Organ colony counts from a series of experiments

Expt no.b Group Dose (mg/kg)
Colony count (mean log10 CFU/g ± SD)a
AMB Mycograb Kidney Liver Spleen
1 1 0.6 2 (9)e (9)d (9)d
2 0.6 0.2 (10)e (10)d (9)d
3 0.6 b3.66 ± 0.82 (4) (9)d (10)d
4 2 b4.58 ± 0.76 (2) b3.50 ± 0.47 (3) b3.12 ± 0.11 (4)
5 0.2 5.1 ± 0.11 (0) 3.85 ± 0.81 (3) 3.35 ± 0.33 (3)
6 5.5 ± 0.5 (0) 4.42 ± 0.59 (2) 3.65 ± 0.69 (2)
2 1 0.6 2 (9)d (9)d (8)d,e
2 0.6 0.2 (9)d (8)d 3.71 ± 0.64 (4)
3 0.6 (9)d (7) b4.18 ± 0.22 (2)
4 2 (6) b4.32 ± 0.82 (4) b3.87 ± 0.93 (1)
5 0.2 (6) b4.35 ± 0.26 (4) b3.81 ± 0.78 (1)
6 4.05 ± 0.1 (0) 5.15 ± 0.18 (0) 4.81 ± 0.33 (0)
3 1 0.6 2 (9)d (6) (8)d,e
2 0.6 0.2 (10)d (6) (8)d,e
3 0.6 (9)d b4.74 ± 1.0 (2) b4.24 ± 0.25 (3)
4 2 (8)d b5.54 ± 0.18 (0) b5.19 ± 0.31 (0)
5 0.2 5.17 ± 0.19 (2) b6.01 ± 0.25 (0) 5.30 ± 0.39 (0)
6 5.19 ± 0.90 (0) 6.57 ± 0.34 (0) 5.86 ± 0.76 (0)
4 1 0.6 2 (8)d (10)d (10)d
2 0.6 0.2 (8)d (10)d (10)d
3 0.6 (8)d (10)d (10)d
4 2 b4.24 ± 0.95 (1) (9)d (10)d
5 0.2 b4.41 ± 0.72 (1) (10)d (10)d
6 5.30 ± 0.13 (0) 3.82 ± 0.69 (1) 4.41 ± 0.93 (3)
5 1 0.6 2 3.82 ± 0.81 (4) (10)d,e (10)d,e
2 0.6 0.2 3.84 ± 0.78 (1) (9)d 3.89 ± 0.94 (2)
3 0.6 4.01 ± 0.93 (1) 3.08 ± 0.12 (5) 4.10 ± 0.98 (0)
4 2 4.01 ± 0.92 (1) (9)d 4.03 ± 0.33 (2)
5 0.2 4.01 ± 0.09 (3) (9)d 4.07 ± 0.31 (3)
6 4.00 ± 0.04 (0) 3.54 ± 0.65 (3) 4.05 ± 0.08 (0)
6 1 0.6 2 b4.56 ± 0.81 (0) b3.66 ± 0.25 (4) b4.08 ± 0.02 (2)
2 0.6 0.2 b4.48 ± 0.34 (0) b4.09 ± 0.27 (2) b4.11 ± 0.29 (1)
3 0.6 b4.62 ± 0.94 (0) b3.98 ± 0.06 (3) b4.24 ± 0.29 (2)
4 2 b4.60 ± 0.65 (0) b4.07 ± 0.26 (3) b4.32 ± 0.31 (1)
5 0.2 b4.77 ± 0.79 (0) b4.28 ± 0.28 (0) b4.48 ± 0.38 (2)
6 5.66 ± 0.64 (0) 5.31 ± 0.44 (0) 5.24 ± 0.16 (0)
a

Number of negative biopsy specimen in parentheses.

b

Experiments: 1, FLC-resistant C. albicans; 2, C. krusei; 3, C. glabrata 4, C. tropicalis; 5, C. parapsilosis; 6, C. parapsilosis (clinical isolate).

c

Statistically significant (Scheffe's test, P < 0.05) versus the control group 6.

d

Statistically significant number of negative biopsy specimens (Fisher's exact test, P < 0.05) versus the control group 6.

e

Statistically significant numbers of negative biopsy specimens (Fisher's exact test, P < 0.05) versus the AMB-treated group 3.